Metabolomics of fecal samples: A practical consideration

Trends in Food Science and Technology

Volumn 57, Issue , 2016, Pages 244-255

  Matysik, Silke ^a   Le Roy, Caroline Ivanne ^b   Liebisch, Gerhard ^a   Claus, Sandrine Paule ^b  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b UNIVERSITY OF READING   (United Kingdom)

Author keywords

Feces; Lipidomics; Metabolomics; Methods

Indexed keywords

BIOMOLECULES; METABOLISM;

FECES; HYDROPHILIC AND HYDROPHOBIC; LIPIDOMICS; METABOLIC INTERACTIONS; METABOLIC PROFILING; METABOLOMICS; METHODS; MICROBIAL METABOLITES;

METABOLITES;

EID: 85001913288     PISSN: 09242244     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tifs.2016.05.011     Document Type: Article

References (108)

1. Ahmed, I., Greenwood, R., de Lacy Costello, B., Ratcliffe, N.M., Probert, C.S., An investigation of fecal volatile organic metabolites in irritable bowel syndrome. PLoS One, 8(3), 2013, e58204, 10.1371/journal.pone.0058204.
2. Ala-Korpela, M., Korhonen, A., Keisala, J., Hörkkö, S., Korpi, P., Ingman, L.P., et al. 1H NMR-based absolute quantitation of human lipoproteins and their lipid contents directly from plasma. Journal of Lipid Research 35:12 (1994), 2292–2304.
3. Ala-Korpela, M., Posio, P., Mattila, S., Korhonen, A., Williams, S.R., Absolute quantification of phospholipid metabolites in brain-tissue extracts by 1 H NMR spectroscopy. Journal of Magnetic Resonance, Series B 113:2 (1996), 184–189.
4. Andrási, N., Helenkár, A., Vasanits-Zsigrai, A., Záray, G., Molnár-Perl, I., The role of the acquisition methods in the analysis of natural and synthetic steroids and cholic acids by gas chromatography-mass spectrometry. Journal of Chromatography A 1218:45 (2011), 8264–8272, 10.1016/j.chroma.2011.09.006.
5. Batta, A.K., Salen, G., Rapole, K.R., Batta, M., Batta, P., Alberts, D., et al. Highly simplified method for gas-liquid chromatographic quantitation of bile acids and sterols in human stool. Journal of Lipid Research 40:6 (1999), 1148–1154.
6. Benno, P., Midtvedt, K., Alam, M., Collinder, E., Norin, E., Midtvedt, T., Examination of intestinal conversion of cholesterol to coprostanol in 633 healthy subjects reveals an age- and sex-dependent pattern. Microbial Ecology in Health and Disease, 17(4), 2005.
7. Besten den, G., van Eunen, K., Groen, A.K., Venema, K., The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. Journal of Lipid Research 54:9 (2013), 2325–2340.
8. Bezabeh, T., Somorjai, R., Dolenko, B., Bryskina, N., Levin, B., Bernstein, C.N., et al. Detecting colorectal cancer by 1H magnetic resonance spectroscopy of fecal extracts. NMR in Biomedicine 22:6 (2009), 593–600.
9. Biagi, E., Candela, M., Fairweather-Tait, S., Franceschi, C., Brigidi, P., Ageing of the human metaorganism: the microbial counterpart. Age 34:1 (2012), 247–267.
10. Binder, M., Liebisch, G., Langmann, T., Schmitz, G., Metabolic profiling of glycerophospholipid synthesis in fibroblasts loaded with free cholesterol and modified low density lipoproteins. Journal of Biological Chemistry 281:31 (2006), 21869–21877.
11. Bjerrum, J.T., Wang, Y., Hao, F., Coskun, M., Ludwig, C., Günther, U., et al. Metabonomics of human fecal extracts characterize ulcerative colitis, Crohn's disease and healthy individuals. Metabolomics 11:1 (2014), 122–133, 10.1007/s11306-014-0677-3.
12. Bligh, E.G., Dyer, W.J., A rapid method of total lipid extraction and purification. Canadian Journal of Biochemistry and Physiology 37:8 (1959), 911–917.
13. Bou Khalil, M., Hou, W., Zhou, H., Elisma, F., Swayne, L.A., Blanchard, A.P., et al. Lipidomics era: accomplishments and challenges. Mass Spectrometry Reviews 29:6 (2010), 877–929.
14. Busse, H.J., Denner, E.B., Lubitz, W., Classification and identification of bacteria: current approaches to an old problem. Overview of methods used in bacterial systematics. Journal of Biotechnology 47:1 (1996), 3–38.
15. Calvani, R., Brasili, E., Praticò, G., Capuani, G., Tomassini, A., Marini, F., et al. Fecal and urinary NMR-based metabolomics unveil an aging signature in mice. Experimental Gerontology 49 (2014), 5–11.
16. Cao, G., Zhang, Y., Feng, J., Cai, H., Zhang, C., Ding, M., et al. A rapid and sensitive assay for determining the main components in processed Fructus corni by UPLC–Q-TOF-MS. Chromatographia 73:1–2 (2011), 135–141.
17. Claesson, M.J., Cusack, S., O'Sullivan, O., Greene-Diniz, R., de Weerd, H., Flannery, E., et al. Composition, variability, and temporal stability of the intestinal microbiota of the elderly. Proceedings of the National Academy of Sciences 108:Suppl. 1 (2011), 4586–4591, 10.1073/pnas.1000097107.
18. Claesson, M.J., Jeffery, I.B., Conde, S., Power, S.E., O'Connor, E.M., Cusack, S., et al. Gut microbiota composition correlates with diet and health in the elderly. Nature 488:7410 (2012), 178–184.
19. Claus, S.P., Ellero, S.L., Berger, B., Krause, L., Bruttin, A., Molina, J., et al. Colonization-induced host-gut microbial metabolic interaction. mBio, 2(2), 2011, 10.1128/mBio.00271-10.
20. Claus, S.P., Swann, J.R., Nutrimetabonomics: applications for nutritional sciences, with specific reference to gut microbial interactions. Annual Review of Food Science and Technology 4 (2013), 381–399, 10.1146/annurev-food-030212-182612.
21. Claus, S.P., Tsang, T.M., Wang, Y., Cloarec, O., Skordi, E., Martin, F.-P., et al. Systemic multicompartmental effects of the gut microbiome on mouse metabolic phenotypes. Molecular Systems Biology, 4(1), 2008, 219, 10.1038/msb.2008.56.
22. Crowther, J.S., Drasar, B.S., Goddard, P., Hill, M.J., Johnson, K., The effect of a chemically defined diet on the faecal flora and faecal steroid concentration. Gut 14:10 (1973), 790–793.
23. David, L.A., Maurice, C.F., Carmody, R.N., Gootenberg, D.B., Button, J.E., Wolfe, B.E., et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 505:7484 (2015), 559–563, 10.1038/nature12820.
24. Davies, J.M., Hua, H.U., Dheer, R., Martinez, M., Bhattacharya, S.K., Abreu, M.T., Stool phospholipid signature is altered by diet and tumors. PloS One, 9(12), 2014, e114352, 10.1371/journal.pone.0114352.
25. De Filippis, F., Pellegrini, N., Vannini, L., Jeffery, I.B., La Storia, A., Laghi, L., et al. High-level adherence to a Mediterranean diet beneficially impacts the gut microbiota and associated metabolome. Gut, 2015 pp. gutjnl-2015.
26. Deda, O., Gika, H.G., Wilson, I.D., Theodoridis, G.A., An overview of fecal sample preparation for global metabolic profiling. Journal of Pharmaceutical and Biomedical Analysis 113 (2015), 137–150.
27. Dixon, E., Clubb, C., Pittman, S., Ammann, L., Rasheed, Z., Kazmi, N., et al. Solid-phase microextraction and the human fecal VOC metabolome. PLoS One, 6(4), 2011, e18471, 10.1371/journal.pone.0018471.
28. Escalona, E.E., Leng, J., Dona, A.C., Merrifield, C.A., Holmes, E., Proudman, C.J., et al. Dominant components of the thoroughbred metabolome characterised by 1H-nuclear magnetic resonance spectroscopy: a metabolite atlas of common biofluids. Equine Veterinary Journal 47:6 (2015), 721–730.
29. Evrard, E., Janssen, G., Gas-liquid chromatographic determination of human fecal bile acids. Journal of Lipid Research 9:2 (1968), 226–236.
30. Eyssen, H., Parmentier, G., Biohydrogenation of sterols and fatty acids by the intestinal microflora. The American Journal of Clinical Nutrition 27:11 (1974), 1329–1340.
31. Fernando, H., Kondraganti, S., Bhopale, K.K., Volk, D.E., Neerathilingam, M., Kaphalia, B.S., et al. 1H and 31P NMR lipidome of ethanol-induced fatty liver. Alcoholism: Clinical and Experimental Research 34:11 (2010), 1937–1947.
32. Flint, H.J., Duncan, S.H., Scott, K.P., Louis, P., Links between diet, gut microbiota composition and gut metabolism. Proceedings of the Nutrition Society 74:01 (2015), 13–22, 10.1017/S0029665114001463.
33. Frost, G.S., Walton, G.E., Swann, J.R., Psichas, A., Costabile, A., Johnson, L.P., et al. Impacts of plant-based foods in ancestral hominin diets on the metabolism and function of gut microbiota in vitro. Mbio, 5(3), 2014 e00853-14.
34. Gao, X., Pujos-Guillot, E., Martin, J., Galan, P., Juste, C., Jia, W., et al. Metabolite analysis of human fecal water by gas chromatography/mass spectrometry with ethyl chloroformate derivatization. Analytical Biochemistry, 393(2), 2009, 163, 10.1016/j.ab.2009.06.036.
35. Gao, X., Pujos-Guillot, E., Sébédio, J., Development of a quantitative metabolomic approach to study clinical human fecal water metabolome based on trimethylsilylation derivatization and GC/MS analysis. Analytical Chemistry, 82(15), 2010, 6447, 10.1021/ac1006552.
36. Gérard, P., Metabolism of cholesterol and bile acids by the gut microbiota. Pathogens 3:1 (2013), 14–24, 10.3390/pathogens3010014.
37. Gregory, K.E., Bird, S.S., Gross, V.S., Marur, V.R., Lazarev, A.V., Walker, W.A., et al. Method development for fecal lipidomics profiling. Analytical Chemistry, 85(2), 2013, 1114, 10.1021/ac303011k.
38. Griffiths, W.J., Sjövall, J., Bile acids: analysis in biological fluids and tissues. Journal of Lipid Research 51:1 (2010), 23–41, 10.1194/jlr.R001941-JLR200.
39. Grundy, S.M., Ahrens, E.H., Measurements of cholesterol turnover, synthesis, and absorption in man, carried out by isotope kinetic and sterol balance methods. Journal of Lipid Research 10:1 (1969), 91–107.
40. Grundy, S.M., Ahrens, E.H., Davignon, J., The interaction of cholesterol absorption and cholesterol synthesis in man. Journal of Lipid Research 10:3 (1969), 304–315.
41. Grundy, S.M., Ahrens, E.H., Miettinen, T.A., Quantitative isolation and gas–liquid chromatographic analysis of total fecal bile acids. Journal of Lipid Research 6 (1965), 397–410.
42. Grundy, S.M., Mok, H.Y., Determination of cholesterol absorption in man by intestinal perfusion. Journal of Lipid Research 18:2 (1977), 263–271.
43. Hagey, L.R., Krasowski, M.D., Microbial biotransformations of bile acids as detected by electrospray mass spectrometry. Advances in Nutrition (Bethesda, Md.) 4:1 (2013), 29–35, 10.3945/an.112.003061.
44. Hagio, M., Matsumoto, M., Fukushima, M., Hara, H., Ishizuka, S., Improved analysis of bile acids in tissues and intestinal contents of rats using LC/ESI-MS. Journal of Lipid Research 50:1 (2009), 173–180, 10.1194/jlr.D800041-JLR200.
45. Han, J., Lin, K., Sequeira, C., Borchers, C.H., An isotope-labeled chemical derivatization method for the quantitation of short-chain fatty acids in human feces by liquid chromatography–tandem mass spectrometry. Analytica Chimica Acta 854 (2015), 86–94.
46. Hebel, T., Eisinger, K., Neumeier, M., Rein-Fischboeck, L., Pohl, R., Meier, E.M., et al. Lipid abnormalities in alpha/beta2-syntrophin null mice are independent from ABCA1. Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids 1851:5 (2015), 527–536.
47. Hofmann, A.F., Bile acids: trying to understand their chemistry and biology with the hope of helping patients. Hepatology 49:5 (2009), 1403–1418.
48. Hofmann, A.F., Eckmann, L., How bile acids confer gut mucosal protection against bacteria. Proceedings of the National Academy of Sciences of the United States of America 103:12 (2006), 4333–4334, 10.1073/pnas.0600780103.
49. Hofmann, A.F., Hagey, L.R., Bile acids: chemistry, pathochemistry, biology, pathobiology, and therapeutics. Cellular and Molecular Life Sciences (CMLS) 65:16 (2008), 2461–2483, 10.1007/s00018-008-7568-6.
50. Hofmann, A.F., Hagey, L.R., Krasowski, M.D., Bile salts of vertebrates: structural variation and possible evolutionary significance. Journal of Lipid Research 51:2 (2010), 226–246, 10.1194/jlr.R000042.
51. Hong, Y.S., Ahn, Y.T., Park, J.C., Lee, J.H., Lee, H., Huh, C.S., et al. 1H NMR-based metabonomic assessment of probiotic effects in a colitis mouse model. Archives of Pharmacal Research 33:7 (2010), 1091–1101.
52. Jacobs, D.M., Deltimple, N., van Velzen, E., Van Dorsten, F.A., Bingham, M., Vaughan, E.E., et al. 1H NMR metabolite profiling of feces as a tool to assess the impact of nutrition on the human microbiome. NMR in Biomedicine 21:6 (2008), 615–626, 10.1002/nbm.1233.
53. Jiménez-Girón, A., Ibáñez, C., Cifuentes, A., Simó, C., Muñoz-González, I., Martín-Álvarez, P.J., et al. Estudio del metaboloma fecal tras el consumo moderado y continuado de vino tinro por individuos sanos. 2015.
54. Kellogg, T.F., Knight, P.L., Wostmann, B.S., Effect of bile acid deconjugation on the fecal excretion of steroids. Journal of Lipid Research 11:4 (1970), 362–366.
55. Korpela, J.T., Capillary gas-liquid chromatography of faecal free and esterified neutral sterols. Scandinavian Journal of Clinical and Laboratory Investigation 42:6 (1982), 529–534.
56. Lamichhane, S., Yde, C.C., Schmedes, M.S., Jensen, H.M., Meier, S., Bertram, H.C., Strategy for nuclear-magnetic-resonance-based metabolomics of human feces. Analytical Chemistry 87:12 (2015), 5930–5937.
57. Le Gall, G., Noor, S.O., Ridgway, K., Scovell, L., Jamieson, C., Johnson, I.T., et al. Metabolomics of fecal extracts detects altered metabolic activity of gut microbiota in ulcerative colitis and irritable bowel syndrome. Journal of Proteome Research 10:9 (2011), 4208–4218, 10.1021/pr2003598.
58. Le Roy, C.I., Štšepetova, J., Sepp, E., Songisepp, E., Claus, S.P., Mikelsaar, M., New insights into the impact of Lactobacillus population on host-bacteria metabolic interplay. Oncotarget 6:31 (2015), 30545–30556.
59. Leidl, K., Liebisch, G., Richter, D., Schmitz, G., Mass spectrometric analysis of lipid species of human circulating blood cells. Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids 1781:10 (2008), 655–664.
60. Lichtenstein, A.H., Intestinal cholesterol metabolism. Annual Medicine, 22(1), 1990.
61. Liebisch, G., Vizcaíno, J.A., Köfeler, H., Trötzmüller, M., Griffiths, W.J., Schmitz, G., et al. Shorthand notation for lipid structures derived from mass spectrometry. Journal of Lipid Research, 2013 pp. jlr-M033506.
62. Li, J.V., Saric, J., Wang, Y., Keiser, J., Utzinger, J., Holmes, E., Chemometric analysis of biofluids from mice experimentally infected with Schistosoma mansoni. Parasites & Vectors, 4, 2011, 179, 10.1186/1756-3305-4-179.
63. Lozupone, C.A., Stombaugh, J.I., Gordon, J.I., Jansson, J.K., Knight, R., Diversity, stability and resilience of the human gut microbiota. Nature 489:7415 (2012), 220–230.
64. Lütjohann, D., Meese, C.O., Crouse, J.R., Bergmann von, K., Evaluation of deuterated cholesterol and deuterated sitostanol for measurement of cholesterol absorption in humans. Journal of Lipid Research 34:6 (1993), 1039–1046.
65. Marchesi, J.R., Holmes, E., Khan, F., Kochhar, S., Scanlan, P., Shanahan, F., et al. Rapid and noninvasive metabonomic characterization of inflammatory bowel disease. Journal of Proteome Research 6:2 (2007), 546–551.
66. Martin, F.-P.J., Sprenger, N., Montoliu, I., Rezzi, S., Kochhar, S., Nicholson, J.K., Dietary modulation of gut functional ecology studied by fecal metabonomics. Journal of Proteome Research 9:10 (2010), 5284–5295, 10.1021/pr100554m.
67. Matyash, V., Liebisch, G., Kurzchalia, T.V., Shevchenko, A., Schwudke, D., Lipid extraction by methyl-tert-butyl ether for high-throughput lipidomics. Journal of Lipid Research 49:5 (2008), 1137–1146.
68. Meiboom, S., Gill, D., Modified spin-echo method for measuring nuclear relaxation times. Review of Scientific Instruments, 29(8), 1958, 688, 10.1063/1.1716296.
69. Midtvedt, T., Lingaas, E., Carlstedt-Duke, B., Höverstad, T., Midtvedt, A.C., Saxerholt, H., et al. Intestinal microbial conversion of cholesterol to coprostanol in man. Influence of antibiotics. APMIS: Acta Pathologica, Microbiologica, Et Immunologica Scandinavica 98:9 (1990), 839–844.
70. Miettinen, T.A., Ahrens, E.H., Grundy, S.M., Quantitative isolation and gas-liquid chromatographic analysis of total dietary and fecal neutral steroids. Journal of Lipid Research 6 (1965), 411–424.
71. Monleon, D., Morales, J.M., Barrasa, A., Lopez, J.A., Vazquez, C., Celda, B., Metabolite profiling of fecal water extracts from human colorectal cancer. NMR in Biomedicine 22:3 (2009), 342–348.
72. Mukherji, A., Kobiita, A., Ye, T., Chambon, P., Homeostasis in intestinal epithelium is orchestrated by the circadian clock and microbiota cues transduced by TLRs. Cell 153:4 (2013), 812–827, 10.1016/j.cell.2013.04.020.
73. Ndagijimana, M., Laghi, L., Vitali, B., Placucci, G., Brigidi, P., Guerzoni, M.E., Effect of a synbiotic food consumption on human gut metabolic profiles evaluated by 1 H nuclear magnetic resonance spectroscopy. International Journal of Food Microbiology 134:1 (2009), 147–153.
74. O'Hara, A.M., Shanahan, F., The gut flora as a forgotten organ. EMBO Reports 7:7 (2006), 688–693, 10.1038/sj.embor.7400731.
75. Owen, R.W., Thompson, M.H., Hill, M.J., Analysis of metabolic profiles of steroids in faeces of healthy subjects undergoing chenodeoxycholic acid treatment by liquid-gel chromatography and gas-liquid chromatography-mass spectrometry. Journal of Steroid Biochemistry 21:5 (1984), 593–600.
76. Palmer, C., Bik, E.M., DiGiulio, D.B., Relman, D.A., Brown, P.O., Development of the human infant intestinal microbiota. PLoS Biol, 5(7), 2007, e177.
77. Perwaiz, S., Mignault, D., Tuchweber, B., Yousef, I.M., Rapid and improved method for the determination of bile acids in human feces using MS. Lipids 37:11 (2002), 1093–1100.
78. Phua, L.C., Chue, X.P., Koh, P.K., Cheah, P.Y., Ho, H.K., Chan, E.C.Y., Non-invasive fecal metabonomic detection of colorectal cancer. Cancer Biology & Therapy 15:4 (2014), 389–397.
79. Phua, L.C., Koh, P.K., Cheah, P.Y., Ho, H.K., Chan, E.C.Y., Global gas chromatography/time-of-flight mass spectrometry (GC/TOFMS)-based metabonomic profiling of lyophilized human feces. Journal of Chromatography B 937 (2013), 103–113.
80. Ridlon, J.M., Kang, D.-J., Hylemon, P.B., Bile salt biotransformations by human intestinal bacteria. Journal of Lipid Research 47:2 (2006), 241–259, 10.1194/jlr.R500013-JLR200.
81. Romick-Rosendale, L.E., Goodpaster, A.M., Hanwright, P.J., Patel, N.B., Wheeler, E.T., Chona, D.L., et al. NMR-based metabonomics analysis of mouse urine and fecal extracts following oral treatment with the broad-spectrum antibiotic enrofloxacin (Baytril). Magnetic Resonance in Chemistry: MRC 47:Suppl. 1 (2009), S36–S46, 10.1002/mrc.2511.
82. Sander, P.R., Peer, M., Grandl, M., Bogdahn, U., Schmitz, G., Kalbitzer, H.R., NMR spectroscopy of macrophages loaded with native, oxidized or enzymatically degraded lipoproteins. PloS One, 8(2), 2013 e56360.
83. Saric, J., Wang, Y., Li, J., Coen, M., Utzinger, J., Marchesi, J.R., et al. Species variation in the fecal metabolome gives insight into differential gastrointestinal function. Journal of Proteome Research 7:1 (2008), 352–360, 10.1021/pr070340k.
84. Sayin, S.I., Wahlström, A., Felin, J., Jäntti, S., Marschall, H.-U., Bamberg, K., et al. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metabolism 17:2 (2013), 225–235, 10.1016/j.cmet.2013.01.003.
85. Scherer, M., Böttcher, A., Liebisch, G., Lipid profiling of lipoproteins by electrospray ionization tandem mass spectrometry. Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids 1811:11 (2011), 918–924.
86. Schiller, J., Arnold, K., Application of high resolution 31P NMR spectroscopy to the characterization of the phospholipid composition of tissues and body fluids-a methodological review. Medical Science Monitor 8:11 (2002), MT205–MT222.
87. Schiller, J., Muller, M., Fuchs, B., Arnold, K., Huster, D., 31P NMR spectroscopy of phospholipids: from micelles to membranes. Current Analytical Chemistry 3:4 (2007), 283–301.
88. Scott, K.P., Duncan, S.H., Flint, H.J., Dietary fibre and the gut microbiota. Nutrition Bulletin 33:3 (2008), 201–211.
89. Setchell, K.D., Ives, J.A., Cashmore, G.C., Lawson, A.M., On the homogeneity of stools with respect to bile acid composition and normal day-to-day variations: a detailed qualitative and quantitative study using capillary column gas chromatography-mass spectrometry. Clinica Chimica Acta 162:3 (1987), 257–275.
90. Setchell, K.D., Lawson, A.M., Tanida, N., Sjövall, J., General methods for the analysis of metabolic profiles of bile acids and related compounds in feces. Journal of Lipid Research 24:8 (1983), 1085–1100.
91. Sigruener, A., Kleber, M.E., Heimerl, S., Liebisch, G., Schmitz, G., Maerz, W., Glycerophospholipid and sphingolipid species and mortality: the Ludwigshafen risk and cardiovascular health (LURIC) study. PloS One, 9(1), 2014, e85724.
92. Snog-Kjaer, A., Prange, I., Dam, H., Conversion of cholesterol into coprosterol by bacteria in vitro. Journal of General Microbiology 14:2 (1956), 256–260.
93. Sonnenburg, E.D., Sonnenburg, J.L., Starving our microbial self: the deleterious consequences of a diet deficient in microbiota-accessible carbohydrates. Cell Metabolism 20:5 (2014), 779–786, 10.1016/j.cmet.2014.07.003.
94. Spritz, N., Ahrens, E.H., Grundy, S., Sterol balance in man as plasma cholesterol concentrations are altered by exchanges of dietary fats. Journal of Clinical Investigation 44:9 (1965), 1482–1493.
95. Story, J.A., Furumoto, E.J., Bile acid analysis: methods and problems. European Journal of Cancer Prevention: The Official Journal of the European Cancer Prevention Organisation (ECP) 1:Suppl. 2 (1991), 29–33.
96. Su, X., Wang, N., Chen, D., Li, Y., Lu, Y., Huan, T., et al. Dansylation isotope labeling liquid chromatography mass spectrometry for parallel profiling of human urinary and fecal submetabolomes. Analytica Chimica Acta 903 (2016), 100–109.
97. Tian, Y., Zhang, L., Wang, Y., Tang, H., Age-related topographical metabolic signatures for the rat gastrointestinal contents. Journal of Proteome Research 11:2 (2011), 1397–1411.
98. Trauner, M., Claudel, T., Fickert, P., Moustafa, T., Wagner, M., Bile acids as regulators of hepatic lipid and glucose metabolism. Digestive Diseases 28:1 (2010), 220–224.
99. Voigt, R.M., Forsyth, C.B., Green, S.J., Mutlu, E., Engen, P., Vitaterna, M.H., et al. Circadian disorganization alters intestinal microbiota. PloS One, 9(5), 2014, e97500, 10.1371/journal.pone.0097500.
100. Weir, T.L., Manter, D.K., Sheflin, A.M., Barnett, B.A., Heuberger, A.L., Ryan, E.P., Stool microbiome and metabolome differences between colorectal cancer patients and healthy adults. PloS One, 8(8), 2013, e70803.
101. Wenk, M.R., Lipidomics: new tools and applications. Cell 143:6 (2010), 888–895, 10.1016/j.cell.2010.11.033.
102. Wu, J., An, Y., Yao, J., Wang, Y., Tang, H., An optimised sample preparation method for NMR-based faecal metabonomic analysis. Analyst 135:5 (2010), 1023–1030.
103. Yap, I.K.S., Li, J.V., Saric, J., Martin, F.-P., Davies, H., Wang, Y., et al. Metabonomic and microbiological analysis of the dynamic effect of vancomycin-induced gut microbiota modification in the mouse. Journal of Proteome Research 7:9 (2008), 3718–3728, 10.1021/pr700864x.
104. Yatsunenko, T., Rey, F.E., Manary, M.J., Trehan, I., Dominguez-Bello, M.G., Contreras, M., et al. Human gut microbiome viewed across age and geography. Nature 486:7402 (2012), 222–227, 10.1038/nature11053.
105. Zhao, Y.Y., Shen, X., Cheng, X.L., Wei, F., Bai, X., Lin, R.C., Urinary metabonomics study on the protective effects of ergosta-4, 6, 8(14), 22-tetraen-3-one on chronic renal failure in rats using UPLC Q-TOF/MS and a novel MS E data collection technique. Process Biochemistry 47:12 (2012), 1980–1987.
106. Zhao, Y., Wu, J., Li, J.V., Zhou, N.Y., Tang, H., Wang, Y., Gut microbiota composition modifies fecal metabolic profiles in mice. Journal of Proteome Research 12:6 (2013), 2987–2999.
107. Zhao, Y.Y., Zhang, L., Long, F.Y., Cheng, X.L., Bai, X., Wei, F., et al. UPLC-Q-TOF/HSMS/MS E-based metabonomics for adenine-induced changes in metabolic profiles of rat faeces and intervention effects of ergosta-4, 6, 8(14), 22-tetraen-3-one. Chemico-biological Interactions 201:1 (2013), 31–38.
108. Zheng, X., Qiu, Y., Zhong, W., Baxter, S., Su, M., Li, Q., et al. A targeted metabolomic protocol for short-chain fatty acids and branched-chain amino acids. Metabolomics 9:4 (2013), 818–827.